Vorapaxar: a novel protease-activated receptor-1 inhibitor

By Gurbel Paul A   Jeong Young-Hoon   Tantry Udaya S  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 10, 2011-10 ,pp. : 1445-1453

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of protease-activated receptor-1 antagonists

By Derian Claudia K   Maryanoff Bruce E   Zhang Han-Cheng   Andrade-Gordon Patricia  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 209-221

Informa Healthcare

Access to resources Recommend Favorite

Allosteric Modulation of Protease-Activated Receptor Signaling

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 9, 2012-08 ,pp. : 804-811

Bentham Science Publishers

Access to resources Recommend Favorite

Thrombin regulates the expression of proangiogenic cytokines via proteolytic activation of protease-activated receptor-1

By Naldini A.   Carney D.H.   Pucci A.   Pasquali A.   Carraro F.  

General Pharmacology, Vol. 35, Iss. 5, 2000-11 ,pp. : 255-259

Elsevier

Access to resources Recommend Favorite

Inhibition of arterial thrombosis by a protease-activated receptor 1 antagonist, FR171113, in the guinea pig

By Kato Y.   Kita Y.   Hirasawa-Taniyama Y.   Nishio M.   Mihara K.   Ito K.   Yamanaka T.   Seki J.   Miyata S.   Mutoh S.  

European Journal of Pharmacology, Vol. 473, Iss. 2, 2003-07 ,pp. : 163-169

Elsevier

Access to resources Recommend Favorite